|
| |
Price : 5 slide for 600 €
| CH1 Human larynx and pharynx cancer |
| |
|
|
|
|
|
|
| |
Age |
Sex |
Location |
Diagnosis |
TNM |
Stage |
| 1 |
43 |
M |
larynx, pyriform sinus |
SCC*, moderately differentiated |
T4N2M0 |
ⅣA |
| 2 |
55 |
M |
larynx, subglottic |
SCC, moderately differentiated |
T4N0M0 |
ⅣA |
| 3 |
72 |
M |
larynx, supraglottic |
SCC, moderately differentiated |
T3N0M0 |
Ⅲ |
| 4 |
63 |
M |
esophagus |
SCC, basaloid type |
T4N0M0 |
ⅣA |
| 5 |
67 |
M |
larynx, transglottic |
SCC, well differentiated |
T4N2bM0 |
ⅣA |
| 6 |
63 |
M |
larynx, pyriform sinus |
SCC, moderately differentiated |
T4N2cM0 |
ⅣA |
| 7 |
60 |
M |
larynx, supraglottic |
SCC, moderately differentiated |
T4N2cM0 |
ⅣA |
| 8 |
61 |
M |
larynx, glottic |
SCC, moderately differentiated |
T4N0M0 |
ⅣA |
| 9 |
66 |
M |
larynx, glottic |
SCC, moderately differentiated |
T4N0M0 |
ⅣA |
| 10 |
56 |
M |
larynx, glottic |
SCC, well differentiated |
T1N0M0 |
Ⅰ |
| 11 |
62 |
M |
larynx, supraglottic |
SCC, moderately differentiated |
T3N2M0 |
ⅣA |
| 12 |
56 |
M |
larynx, pyriform sinus |
SCC, moderately differentiated |
T4N2bM0 |
ⅣA |
| 13 |
54 |
M |
larynx, supraglottic |
SCC, well differentiated |
T3N0M0 |
Ⅲ |
| 14 |
48 |
M |
larynx, transglottic |
SCC, well differentiated |
T3N0M0 |
Ⅲ |
| 15 |
61 |
M |
larynx, supraglottic |
SCC, well differentiated |
T3N0M0 |
Ⅲ |
| 16 |
66 |
M |
soft tissue of neck |
SCC, well differentiated of hypopharynx |
T4N0M0 |
Ⅳ |
| 17 |
51 |
M |
larynx, supraglottic |
SCC, moderately differentiated |
T4N2cM0 |
ⅣA |
| 18 |
46 |
M |
soft tissue, neck |
SCC of hypopharynx |
T2N3M0 |
ⅣB |
| 19 |
52 |
M |
larynx, supraglottic |
SCC, moderately differentiated |
T2N0M0 |
Ⅱ |
| 20 |
52 |
F |
Nasal cavity |
undifferentiated carcinoma |
T4NxM0 |
ⅣA |
| 21 |
64 |
M |
larynx, transglottic |
basaloid SCC |
T3N1M0 |
Ⅲ |
| 22 |
28 |
F |
lymph node |
undifferentiated carcinoma from nasopharynx |
T1N2cMx |
0 |
| 23 |
63 |
M |
Nasopharynx |
undifferentiated carcinoma |
TxN2M1 |
ⅣC |
| 24 |
77 |
M |
Neck |
undifferentiated carcinoma |
TxN2M0 |
ⅣA |
| 25 |
51 |
M |
larynx, transglottic |
SCC, well differentiated |
T4N2M0 |
ⅣA |
| 26 |
51 |
M |
hypopharynx |
SCC, moderately differentiated |
TxN1M0 |
Ⅲ |
| 27 |
59 |
M |
nasal cavity |
SCC, poorly differentiated |
T4N0M0 |
ⅣA |
| 28 |
55 |
M |
larynx, subglottic |
SCC, moderately differentiated |
T3N0M0 |
Ⅲ |
| 29 |
60 |
M |
larynx, transglottic |
Larynx, SCC, well differentiated |
T4N0M0 |
ⅣA |
| 30 |
70 |
M |
oropharynx |
undifferentiated carcinoma |
T1N2aM0 |
ⅣA |
| 31 |
55 |
M |
hypopharynx |
squamous cell carcinoma, poorly differentiated |
T4N2bM0 |
ⅣA |
| 32 |
62 |
M |
larynx, pyriform sinus |
SCC |
T3N0M0 |
Ⅲ |
| 33 |
48 |
M |
soft tissue, neck |
SCC from larynx |
T2N1M0 |
Ⅲ |
| 34 |
66 |
M |
larynx, supraglottic |
SCC, moderately differentiated |
T4N2bM0 |
ⅣA |
| 35 |
58 |
M |
larynx, transglottic |
SCC, well differentiated |
T3N0M0 |
Ⅲ |
| 36 |
76 |
M |
larynx, supraglottic |
SCC, moderately differentiated |
T3N1M0 |
Ⅲ |
| 37 |
61 |
M |
larynx, supraglottic |
SCC, well differentiated |
T4N2bM0 |
ⅣA |
| 38 |
66 |
M |
submandibular gland |
undifferentiated ca. with lymphoid stroma |
T3N2M0 |
Ⅳ |
| 39 |
54 |
M |
tonsil |
SCC, poorly differentiated |
T2N2bM0 |
ⅣA |
| 40 |
61 |
M |
nose |
SCC, poorly differentiated |
T3N0M0 |
Ⅲ |
| 41 |
65 |
M |
larynx, glottic |
Larynx, SCC, moderately differentiated |
T4NxM1 |
ⅣC |
| 42 |
54 |
M |
skin, neck |
undifferentiated carcinoma from nasopharynx |
T4N2aM0 |
ⅣA |
| 43 |
82 |
F |
larynx, supraglottic |
SCC, moderately differentiated |
T3N1M0 |
Ⅲ |
| 44 |
56 |
M |
larynx, subglottic |
SCC |
T4N2bM0 |
ⅣA |
| 45 |
75 |
M |
larynx, transglottic |
SCC, well differentiated |
T4N0M0 |
ⅣA |
| 46 |
69 |
M |
larynx, glottic |
SCC, poorly differentiated |
T4N2bM0 |
ⅣA |
| 47 |
43 |
M |
larynx, subglottic |
SCC, moderately differentiated |
T3N0M0 |
Ⅲ |
| 48 |
60 |
M |
larynx, glottic |
SCC |
T4N0M0 |
ⅣA |
| 49 |
66 |
M |
larynx, supraglottic |
SCC, poorly differentiated |
T2N0M0 |
Ⅱ |
| 50 |
34 |
F |
breast |
medullary carcinoma |
TNM |
0 |
| 51 |
58 |
M |
larynx, pyriform sinus |
SCC |
T3N2bM0 |
ⅣA |
| 52 |
47 |
F |
maxilla |
undifferentiated carcinoma |
T1N0M0 |
Ⅰ |
| 53 |
65 |
M |
larynx, glottic |
SCC, well differentiated |
T4N2M0 |
ⅣA |
| 54 |
78 |
M |
larynx, supraglottic |
SCC, moderately differentiated |
T4N1M0 |
ⅣA |
| 55 |
69 |
M |
epiglottis |
basaloid SCC |
T2N0M0 |
Ⅱ |
| 56 |
60 |
M |
epiglottis |
SCC, moderately differentiated |
T2N3M0 |
ⅣB |
| 57 |
46 |
F |
lymph node, neck |
undifferentiated ca., primary site unknown |
TNM |
0 |
| 58 |
70 |
M |
larynx, glottic |
SCC, poorly differentiated |
T4N2M0 |
ⅣA |
| 59 |
79 |
M |
larynx, supraglottic |
SCC, poorly differentiated |
T3N2bM0 |
ⅣA |
| 60 |
52 |
M |
larynx, supraglottic |
SCC |
T3N1M0 |
Ⅲ |
| |
|
|
|
|
|
|
| *SCC: squamous cell carcinoma |
|
|
|
| TNM and stage classification : larynx and pharynx cancer (AJCC 5th
Edition) |
|
|
General Information of the Tissue Array Slide :
Applications
- Immunohistochemistry
- In situ hybridization, RNA or DNA
- Fluorescent in situ hybridization (FISH)
- In situ PCR, RNA or DNA
- TUNEL for apoptosis (Recommended procedures in
www.tissue-array.com -> protocol)
Storage and stability
- Individual slide is paraffin-coated and put in an air-tight pack
with inert gas.
- Tissue array slides are shipped in room temperature.
- If the slides are stored in 4 degree, they are good up to one
year.
How processed
- Tissues were initially fixed with formalin except for some of the
animal tissues.
- Then, dehydrated with gradient ethanol; typically 1 hour each
progressive steps; 70%, 90%, 95%, 99%, 100% x 3 times.
- Cleared by xylene, three changes for 1 hour each.
- Infiltrated with 60°C paraffin, three changes for 1 hour each
- Microtoming in 4 µm thickness and put on silane coating slide from
Muto Pure Chemicals (Japan)
Before use
- Dry slides for 1 hour in a oven at 60 degree.
- Dewax slides in xylene for 4 minutes x 5 times
- Hydrate slides in 100%, 95% and 75% ethanol for 3 minutes x 2
times each.
- Immerse slides in tap water for 5 minutes
Slide orientation
- In most of the slides with 59 or 60 cores, the orientation is as
below unless indicated otherwise. #60 location is usually filled with carbon
for orientation.
| 1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
| 11 |
12 |
13 |
14 |
15 |
16 |
17 |
18 |
19 |
20 |
| 21 |
22 |
23 |
24 |
25 |
26 |
27 |
28 |
29 |
30 |
| 31 |
32 |
33 |
34 |
35 |
36 |
37 |
38 |
39 |
40 |
| 41 |
42 |
43 |
44 |
45 |
46 |
47 |
48 |
49 |
50 |
| 51 |
52 |
53 |
54 |
55 |
56 |
57 |
58 |
59 |
60 |
|